| 1 | objectives | 3,255 |
| 2 | keywords | 619 |
| 3 | 36-item | 375 |
| 4 | 12-item | 144 |
| 5 | secretary | 33 |
| 6 | short-form-36 | 26 |
| 7 | pinnacle | 19 |
| 8 | diplotypes | 18 |
| 9 | readership | 11 |
| 10 | osteo-cise | 7 |
| 11 | scfs | 6 |
| 12 | cumulants | 5 |
| 13 | key-words | 5 |
| 14 | phytoflagellates | 5 |
| 15 | pre-cpoe | 5 |
| 16 | video-recordings | 5 |
| 17 | backcountry | 4 |
| 18 | intertwining | 4 |
| 19 | isocycles | 4 |
| 20 | llha | 4 |
| 21 | lumos | 4 |
| 22 | neovagina | 4 |
| 23 | oro-pharynx | 4 |
| 24 | phycobionts | 4 |
| 25 | preclusion | 4 |
| 26 | 'innere | 3 |
| 27 | 8-items | 3 |
| 28 | argyle | 3 |
| 29 | chairmen | 3 |
| 30 | e1199 | 3 |
| 31 | erythrocondylomata | 3 |
| 32 | ethanol-extract | 3 |
| 33 | lsbs | 3 |
| 34 | microlenses | 3 |
| 35 | non-overlap | 3 |
| 36 | rest.deaths | 3 |
| 37 | scid-p | 3 |
| 38 | srp+er | 3 |
| 39 | successfulness | 3 |
| 40 | telis | 3 |
| 41 | yang-style | 3 |
| 42 | 1970-1980s | 2 |
| 43 | 2.5metg | 2 |
| 44 | 2010s | 2 |
| 45 | 3-driuds | 2 |
| 46 | 36-question | 2 |
| 47 | 37cl-akie | 2 |
| 48 | aminomorphinans | 2 |
| 49 | anharmonicities | 2 |
| 50 | arm-patients | 2 |
| 51 | beam-ends | 2 |
| 52 | certificateless | 2 |
| 53 | codis | 2 |
| 54 | deazaflavins | 2 |
| 55 | dsmt | 2 |
| 56 | fim-locomotor | 2 |
| 57 | gnu | 2 |
| 58 | hyphosphere | 2 |
| 59 | ice-creams | 2 |
| 60 | ileums | 2 |
| 61 | logor | 2 |
| 62 | m-values | 2 |
| 63 | non-effectiveness | 2 |
| 64 | objectivesto | 2 |
| 65 | off-springs | 2 |
| 66 | outcomes.• | 2 |
| 67 | peer-interactions | 2 |
| 68 | pik3ca-targeted | 2 |
| 69 | pufa-index | 2 |
| 70 | re-initialization | 2 |
| 71 | sgi-cog | 2 |
| 72 | sporophytes | 2 |
| 73 | taucs | 2 |
| 74 | 'arab | 1 |
| 75 | 'beta-lactam | 1 |
| 76 | 'bureaucracy | 1 |
| 77 | 'vragenlijst | 1 |
| 78 | 1-dapap-derivatives | 1 |
| 79 | 1-glucosyl-5-halogeno-1,2,3-triazoles | 1 |
| 80 | 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4h-indazol-4-ones | 1 |
| 81 | 14/4/2010 | 1 |
| 82 | 2-aryl-3h-indol-3-ones | 1 |
| 83 | 24-posture | 1 |
| 84 | 3,3-diaryloxindoles | 1 |
| 85 | 3-aminoglycosides | 1 |
| 86 | 3-aryl-3-arylmethoxyazetidines | 1 |
| 87 | 3-phenyl-1,2,4-triazin-6-ones | 1 |
| 88 | 36.secondary | 1 |
| 89 | 3wj | 1 |
| 90 | 4-fluoroquinolones | 1 |
| 91 | 5-halouracils | 1 |
| 92 | 6-dimensional | 1 |
| 93 | 6112 | 1 |
| 94 | 8,14-dihydroxyefaviremz | 1 |
| 95 | 8676 | 1 |
| 96 | 9,10-epoxide | 1 |
| 97 | a-velocities | 1 |
| 98 | acr-criteria | 1 |
| 99 | advocacies | 1 |
| 100 | aerobactine | 1 |
| 101 | after-period | 1 |
| 102 | agnw-pedot | 1 |
| 103 | aire-study | 1 |
| 104 | alkanals | 1 |
| 105 | ampa-receptor | 1 |
| 106 | analysis-and | 1 |
| 107 | analysis.a | 1 |
| 108 | angiographicaly | 1 |
| 109 | anti-dp | 1 |
| 110 | aphorismic | 1 |
| 111 | applications/fractions | 1 |
| 112 | audit-questionnaire | 1 |
| 113 | auto-responsibility | 1 |
| 114 | b3lyp/aug-cc-pvtz | 1 |
| 115 | beads.harms | 1 |
| 116 | before-period | 1 |
| 117 | bernheim | 1 |
| 118 | better-educated | 1 |
| 119 | bilirubin-ugt | 1 |
| 120 | bisabolenols | 1 |
| 121 | br⋯h | 1 |
| 122 | c25p | 1 |
| 123 | cardiovasculature | 1 |
| 124 | care.trial | 1 |
| 125 | carevent | 1 |
| 126 | cis-angles | 1 |
| 127 | clinician-subjects | 1 |
| 128 | cnpcs | 1 |
| 129 | co-participants | 1 |
| 130 | co2-laser-surgery | 1 |
| 131 | com-on-checklist | 1 |
| 132 | combined-syndromes | 1 |
| 133 | community.inclusion | 1 |
| 134 | consultation.they | 1 |
| 135 | cop1-4 | 1 |
| 136 | core-shells | 1 |
| 137 | counter-medications | 1 |
| 138 | cox-analysis | 1 |
| 139 | criteria® | 1 |
| 140 | crkps | 1 |
| 141 | cycloaddends | 1 |
| 142 | desolation | 1 |
| 143 | dihydrosteroids | 1 |
| 144 | dreamtrial | 1 |
| 145 | dual-rooted | 1 |
| 146 | duocarmycins | 1 |
| 147 | esd-database | 1 |
| 148 | estimate.low | 1 |
| 149 | ff-stabs | 1 |
| 150 | field.trials | 1 |
| 151 | filamins | 1 |
| 152 | finnish-validated | 1 |
| 153 | first-generation-320-detector-row-ct | 1 |
| 154 | fisherwomen | 1 |
| 155 | fmri-paradigm | 1 |
| 156 | fymcs | 1 |
| 157 | galectin3/hbme1 | 1 |
| 158 | gmf-rises | 1 |
| 159 | heat-box | 1 |
| 160 | heteropil | 1 |
| 161 | home-futures | 1 |
| 162 | human-capital-approach | 1 |
| 163 | hypotheses/outcomes | 1 |
| 164 | iaat/scat-ratio | 1 |
| 165 | icf-definition | 1 |
| 166 | idsa-us | 1 |
| 167 | ihhts | 1 |
| 168 | impression-taking | 1 |
| 169 | impuries | 1 |
| 170 | inafnts | 1 |
| 171 | inco-test | 1 |
| 172 | incompletions | 1 |
| 173 | indoor-premises | 1 |
| 174 | intent-to-treat-analysis | 1 |
| 175 | it-mais/mais | 1 |
| 176 | jesuits | 1 |
| 177 | job.conclusions | 1 |
| 178 | karşıyaka | 1 |
| 179 | keggin-anion | 1 |
| 180 | keywords/combinations | 1 |
| 181 | kokmen | 1 |
| 182 | laboratory-we | 1 |
| 183 | lkb-ntcp | 1 |
| 184 | lsmrs | 1 |
| 185 | macro-organism | 1 |
| 186 | mandais | 1 |
| 187 | marsh-classification | 1 |
| 188 | mbcs/mfc | 1 |
| 189 | medically-harmful | 1 |
| 190 | mesh-database | 1 |
| 191 | metabolics | 1 |
| 192 | microimmunoassay | 1 |
| 193 | mini-compacts | 1 |
| 194 | miseraecordae | 1 |
| 195 | mmfr | 1 |
| 196 | molvvs | 1 |
| 197 | monofluoromethylated-adducts | 1 |
| 198 | mortuary | 1 |
| 199 | nannofluids | 1 |
| 200 | neodynium | 1 |
| 201 | neotendons | 1 |
| 202 | non-cri | 1 |
| 203 | non-enrolees | 1 |
| 204 | null-genotype | 1 |
| 205 | n–6 | 1 |
| 206 | off-answer | 1 |
| 207 | outcome.conclusions | 1 |
| 208 | outcomes.results | 1 |
| 209 | outcomes.studies | 1 |
| 210 | p53dbd | 1 |
| 211 | pairwise-distances | 1 |
| 212 | papagos | 1 |
| 213 | paracetamol-group | 1 |
| 214 | participants-general | 1 |
| 215 | participants/interventions | 1 |
| 216 | pc-scores | 1 |
| 217 | pcrrs | 1 |
| 218 | pcuacrs | 1 |
| 219 | perioptic | 1 |
| 220 | pet23a | 1 |
| 221 | ph-minima | 1 |
| 222 | photo-currents | 1 |
| 223 | pilot.patients | 1 |
| 224 | plus-japanese | 1 |
| 225 | pmos | 1 |
| 226 | pre-to-post-improvements | 1 |
| 227 | pre-values | 1 |
| 228 | proteins-one | 1 |
| 229 | pseudosymmetries | 1 |
| 230 | pyrolyzates | 1 |
| 231 | questiones | 1 |
| 232 | radio-listeners | 1 |
| 233 | ratkowsky | 1 |
| 234 | read-backs | 1 |
| 235 | rectums | 1 |
| 236 | registy | 1 |
| 237 | response-outcomes | 1 |
| 238 | ri-values | 1 |
| 239 | road-connections | 1 |
| 240 | rotterdam-rijnmond | 1 |
| 241 | ryukyus | 1 |
| 242 | saliencies | 1 |
| 243 | same.results | 1 |
| 244 | sf-measurements | 1 |
| 245 | sickbeds | 1 |
| 246 | sitting-type | 1 |
| 247 | somit-trial | 1 |
| 248 | sos-chromotest | 1 |
| 249 | spiropentanes | 1 |
| 250 | spring-gauzes | 1 |
| 251 | sri/ssris | 1 |
| 252 | stem-tips | 1 |
| 253 | studies.antibiotics | 1 |
| 254 | study.subjects | 1 |
| 255 | subscales/items | 1 |
| 256 | subtext | 1 |
| 257 | sugar-coat | 1 |
| 258 | sulphatrimethoprims | 1 |
| 259 | tdc-procedure | 1 |
| 260 | tgl-profiles | 1 |
| 261 | thiry-six-item | 1 |
| 262 | timberline | 1 |
| 263 | tme-study | 1 |
| 264 | toes/forefoot | 1 |
| 265 | tube/devices | 1 |
| 266 | vases | 1 |
| 267 | vociferous | 1 |
| 268 | wave-function | 1 |
| 269 | weissenau | 1 |
| 270 | z-form | 1 |
| 271 | zazas | 1 |
| 272 | α-nayf4 | 1 |
| 273 | α-thioglycosides | 1 |
| 274 | ν=2/3 | 1 |
| 1 | 'arab | 1 |
| 2 | 'beta-lactam | 1 |
| 3 | 'bureaucracy | 1 |
| 4 | 'innere | 3 |
| 5 | 'vragenlijst | 1 |
| 6 | 1-dapap-derivatives | 1 |
| 7 | 1-glucosyl-5-halogeno-1,2,3-triazoles | 1 |
| 8 | 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4h-indazol-4-ones | 1 |
| 9 | 12-item | 144 |
| 10 | 14/4/2010 | 1 |
| 11 | 1970-1980s | 2 |
| 12 | 2-aryl-3h-indol-3-ones | 1 |
| 13 | 2.5metg | 2 |
| 14 | 2010s | 2 |
| 15 | 24-posture | 1 |
| 16 | 3,3-diaryloxindoles | 1 |
| 17 | 3-aminoglycosides | 1 |
| 18 | 3-aryl-3-arylmethoxyazetidines | 1 |
| 19 | 3-driuds | 2 |
| 20 | 3-phenyl-1,2,4-triazin-6-ones | 1 |
| 21 | 36-item | 375 |
| 22 | 36-question | 2 |
| 23 | 36.secondary | 1 |
| 24 | 37cl-akie | 2 |
| 25 | 3wj | 1 |
| 26 | 4-fluoroquinolones | 1 |
| 27 | 5-halouracils | 1 |
| 28 | 6-dimensional | 1 |
| 29 | 6112 | 1 |
| 30 | 8,14-dihydroxyefaviremz | 1 |
| 31 | 8-items | 3 |
| 32 | 8676 | 1 |
| 33 | 9,10-epoxide | 1 |
| 34 | a-velocities | 1 |
| 35 | acr-criteria | 1 |
| 36 | advocacies | 1 |
| 37 | aerobactine | 1 |
| 38 | after-period | 1 |
| 39 | agnw-pedot | 1 |
| 40 | aire-study | 1 |
| 41 | alkanals | 1 |
| 42 | aminomorphinans | 2 |
| 43 | ampa-receptor | 1 |
| 44 | analysis-and | 1 |
| 45 | analysis.a | 1 |
| 46 | angiographicaly | 1 |
| 47 | anharmonicities | 2 |
| 48 | anti-dp | 1 |
| 49 | aphorismic | 1 |
| 50 | applications/fractions | 1 |
| 51 | argyle | 3 |
| 52 | arm-patients | 2 |
| 53 | audit-questionnaire | 1 |
| 54 | auto-responsibility | 1 |
| 55 | b3lyp/aug-cc-pvtz | 1 |
| 56 | backcountry | 4 |
| 57 | beads.harms | 1 |
| 58 | beam-ends | 2 |
| 59 | before-period | 1 |
| 60 | bernheim | 1 |
| 61 | better-educated | 1 |
| 62 | bilirubin-ugt | 1 |
| 63 | bisabolenols | 1 |
| 64 | br⋯h | 1 |
| 65 | c25p | 1 |
| 66 | cardiovasculature | 1 |
| 67 | care.trial | 1 |
| 68 | carevent | 1 |
| 69 | certificateless | 2 |
| 70 | chairmen | 3 |
| 71 | cis-angles | 1 |
| 72 | clinician-subjects | 1 |
| 73 | cnpcs | 1 |
| 74 | co-participants | 1 |
| 75 | co2-laser-surgery | 1 |
| 76 | codis | 2 |
| 77 | com-on-checklist | 1 |
| 78 | combined-syndromes | 1 |
| 79 | community.inclusion | 1 |
| 80 | consultation.they | 1 |
| 81 | cop1-4 | 1 |
| 82 | core-shells | 1 |
| 83 | counter-medications | 1 |
| 84 | cox-analysis | 1 |
| 85 | criteria® | 1 |
| 86 | crkps | 1 |
| 87 | cumulants | 5 |
| 88 | cycloaddends | 1 |
| 89 | deazaflavins | 2 |
| 90 | desolation | 1 |
| 91 | dihydrosteroids | 1 |
| 92 | diplotypes | 18 |
| 93 | dreamtrial | 1 |
| 94 | dsmt | 2 |
| 95 | dual-rooted | 1 |
| 96 | duocarmycins | 1 |
| 97 | e1199 | 3 |
| 98 | erythrocondylomata | 3 |
| 99 | esd-database | 1 |
| 100 | estimate.low | 1 |
| 101 | ethanol-extract | 3 |
| 102 | ff-stabs | 1 |
| 103 | field.trials | 1 |
| 104 | filamins | 1 |
| 105 | fim-locomotor | 2 |
| 106 | finnish-validated | 1 |
| 107 | first-generation-320-detector-row-ct | 1 |
| 108 | fisherwomen | 1 |
| 109 | fmri-paradigm | 1 |
| 110 | fymcs | 1 |
| 111 | galectin3/hbme1 | 1 |
| 112 | gmf-rises | 1 |
| 113 | gnu | 2 |
| 114 | heat-box | 1 |
| 115 | heteropil | 1 |
| 116 | home-futures | 1 |
| 117 | human-capital-approach | 1 |
| 118 | hyphosphere | 2 |
| 119 | hypotheses/outcomes | 1 |
| 120 | iaat/scat-ratio | 1 |
| 121 | ice-creams | 2 |
| 122 | icf-definition | 1 |
| 123 | idsa-us | 1 |
| 124 | ihhts | 1 |
| 125 | ileums | 2 |
| 126 | impression-taking | 1 |
| 127 | impuries | 1 |
| 128 | inafnts | 1 |
| 129 | inco-test | 1 |
| 130 | incompletions | 1 |
| 131 | indoor-premises | 1 |
| 132 | intent-to-treat-analysis | 1 |
| 133 | intertwining | 4 |
| 134 | isocycles | 4 |
| 135 | it-mais/mais | 1 |
| 136 | jesuits | 1 |
| 137 | job.conclusions | 1 |
| 138 | karşıyaka | 1 |
| 139 | keggin-anion | 1 |
| 140 | key-words | 5 |
| 141 | keywords | 619 |
| 142 | keywords/combinations | 1 |
| 143 | kokmen | 1 |
| 144 | laboratory-we | 1 |
| 145 | lkb-ntcp | 1 |
| 146 | llha | 4 |
| 147 | logor | 2 |
| 148 | lsbs | 3 |
| 149 | lsmrs | 1 |
| 150 | lumos | 4 |
| 151 | m-values | 2 |
| 152 | macro-organism | 1 |
| 153 | mandais | 1 |
| 154 | marsh-classification | 1 |
| 155 | mbcs/mfc | 1 |
| 156 | medically-harmful | 1 |
| 157 | mesh-database | 1 |
| 158 | metabolics | 1 |
| 159 | microimmunoassay | 1 |
| 160 | microlenses | 3 |
| 161 | mini-compacts | 1 |
| 162 | miseraecordae | 1 |
| 163 | mmfr | 1 |
| 164 | molvvs | 1 |
| 165 | monofluoromethylated-adducts | 1 |
| 166 | mortuary | 1 |
| 167 | nannofluids | 1 |
| 168 | neodynium | 1 |
| 169 | neotendons | 1 |
| 170 | neovagina | 4 |
| 171 | non-cri | 1 |
| 172 | non-effectiveness | 2 |
| 173 | non-enrolees | 1 |
| 174 | non-overlap | 3 |
| 175 | null-genotype | 1 |
| 176 | n–6 | 1 |
| 177 | objectives | 3,255 |
| 178 | objectivesto | 2 |
| 179 | off-answer | 1 |
| 180 | off-springs | 2 |
| 181 | oro-pharynx | 4 |
| 182 | osteo-cise | 7 |
| 183 | outcome.conclusions | 1 |
| 184 | outcomes.results | 1 |
| 185 | outcomes.studies | 1 |
| 186 | outcomes.• | 2 |
| 187 | p53dbd | 1 |
| 188 | pairwise-distances | 1 |
| 189 | papagos | 1 |
| 190 | paracetamol-group | 1 |
| 191 | participants-general | 1 |
| 192 | participants/interventions | 1 |
| 193 | pc-scores | 1 |
| 194 | pcrrs | 1 |
| 195 | pcuacrs | 1 |
| 196 | peer-interactions | 2 |
| 197 | perioptic | 1 |
| 198 | pet23a | 1 |
| 199 | ph-minima | 1 |
| 200 | photo-currents | 1 |
| 201 | phycobionts | 4 |
| 202 | phytoflagellates | 5 |
| 203 | pik3ca-targeted | 2 |
| 204 | pilot.patients | 1 |
| 205 | pinnacle | 19 |
| 206 | plus-japanese | 1 |
| 207 | pmos | 1 |
| 208 | pre-cpoe | 5 |
| 209 | pre-to-post-improvements | 1 |
| 210 | pre-values | 1 |
| 211 | preclusion | 4 |
| 212 | proteins-one | 1 |
| 213 | pseudosymmetries | 1 |
| 214 | pufa-index | 2 |
| 215 | pyrolyzates | 1 |
| 216 | questiones | 1 |
| 217 | radio-listeners | 1 |
| 218 | ratkowsky | 1 |
| 219 | re-initialization | 2 |
| 220 | read-backs | 1 |
| 221 | readership | 11 |
| 222 | rectums | 1 |
| 223 | registy | 1 |
| 224 | response-outcomes | 1 |
| 225 | rest.deaths | 3 |
| 226 | ri-values | 1 |
| 227 | road-connections | 1 |
| 228 | rotterdam-rijnmond | 1 |
| 229 | ryukyus | 1 |
| 230 | saliencies | 1 |
| 231 | same.results | 1 |
| 232 | scfs | 6 |
| 233 | scid-p | 3 |
| 234 | secretary | 33 |
| 235 | sf-measurements | 1 |
| 236 | sgi-cog | 2 |
| 237 | short-form-36 | 26 |
| 238 | sickbeds | 1 |
| 239 | sitting-type | 1 |
| 240 | somit-trial | 1 |
| 241 | sos-chromotest | 1 |
| 242 | spiropentanes | 1 |
| 243 | sporophytes | 2 |
| 244 | spring-gauzes | 1 |
| 245 | sri/ssris | 1 |
| 246 | srp+er | 3 |
| 247 | stem-tips | 1 |
| 248 | studies.antibiotics | 1 |
| 249 | study.subjects | 1 |
| 250 | subscales/items | 1 |
| 251 | subtext | 1 |
| 252 | successfulness | 3 |
| 253 | sugar-coat | 1 |
| 254 | sulphatrimethoprims | 1 |
| 255 | taucs | 2 |
| 256 | tdc-procedure | 1 |
| 257 | telis | 3 |
| 258 | tgl-profiles | 1 |
| 259 | thiry-six-item | 1 |
| 260 | timberline | 1 |
| 261 | tme-study | 1 |
| 262 | toes/forefoot | 1 |
| 263 | tube/devices | 1 |
| 264 | vases | 1 |
| 265 | video-recordings | 5 |
| 266 | vociferous | 1 |
| 267 | wave-function | 1 |
| 268 | weissenau | 1 |
| 269 | yang-style | 3 |
| 270 | z-form | 1 |
| 271 | zazas | 1 |
| 272 | α-nayf4 | 1 |
| 273 | α-thioglycosides | 1 |
| 274 | ν=2/3 | 1 |
| 1 | 14/4/2010 | 1 |
| 2 | galectin3/hbme1 | 1 |
| 3 | 6112 | 1 |
| 4 | ν=2/3 | 1 |
| 5 | cop1-4 | 1 |
| 6 | α-nayf4 | 1 |
| 7 | short-form-36 | 26 |
| 8 | 8676 | 1 |
| 9 | n–6 | 1 |
| 10 | e1199 | 3 |
| 11 | analysis.a | 1 |
| 12 | pet23a | 1 |
| 13 | llha | 4 |
| 14 | acr-criteria | 1 |
| 15 | karşıyaka | 1 |
| 16 | ph-minima | 1 |
| 17 | neovagina | 4 |
| 18 | erythrocondylomata | 3 |
| 19 | 'arab | 1 |
| 20 | mbcs/mfc | 1 |
| 21 | aphorismic | 1 |
| 22 | perioptic | 1 |
| 23 | p53dbd | 1 |
| 24 | better-educated | 1 |
| 25 | finnish-validated | 1 |
| 26 | pik3ca-targeted | 2 |
| 27 | dual-rooted | 1 |
| 28 | analysis-and | 1 |
| 29 | rotterdam-rijnmond | 1 |
| 30 | before-period | 1 |
| 31 | after-period | 1 |
| 32 | miseraecordae | 1 |
| 33 | 9,10-epoxide | 1 |
| 34 | 37cl-akie | 2 |
| 35 | pinnacle | 19 |
| 36 | argyle | 3 |
| 37 | yang-style | 3 |
| 38 | timberline | 1 |
| 39 | aerobactine | 1 |
| 40 | proteins-one | 1 |
| 41 | pre-cpoe | 5 |
| 42 | sitting-type | 1 |
| 43 | null-genotype | 1 |
| 44 | hyphosphere | 2 |
| 45 | 'innere | 3 |
| 46 | audit-questionnaire | 1 |
| 47 | tdc-procedure | 1 |
| 48 | cardiovasculature | 1 |
| 49 | 24-posture | 1 |
| 50 | esd-database | 1 |
| 51 | mesh-database | 1 |
| 52 | plus-japanese | 1 |
| 53 | osteo-cise | 7 |
| 54 | laboratory-we | 1 |
| 55 | impression-taking | 1 |
| 56 | intertwining | 4 |
| 57 | sgi-cog | 2 |
| 58 | 2.5metg | 2 |
| 59 | human-capital-approach | 1 |
| 60 | br⋯h | 1 |
| 61 | non-cri | 1 |
| 62 | 3wj | 1 |
| 63 | somit-trial | 1 |
| 64 | care.trial | 1 |
| 65 | dreamtrial | 1 |
| 66 | 6-dimensional | 1 |
| 67 | participants-general | 1 |
| 68 | heteropil | 1 |
| 69 | medically-harmful | 1 |
| 70 | 'beta-lactam | 1 |
| 71 | 12-item | 144 |
| 72 | 36-item | 375 |
| 73 | thiry-six-item | 1 |
| 74 | fmri-paradigm | 1 |
| 75 | bernheim | 1 |
| 76 | z-form | 1 |
| 77 | macro-organism | 1 |
| 78 | neodynium | 1 |
| 79 | kokmen | 1 |
| 80 | fisherwomen | 1 |
| 81 | chairmen | 3 |
| 82 | keggin-anion | 1 |
| 83 | preclusion | 4 |
| 84 | community.inclusion | 1 |
| 85 | marsh-classification | 1 |
| 86 | desolation | 1 |
| 87 | re-initialization | 2 |
| 88 | wave-function | 1 |
| 89 | icf-definition | 1 |
| 90 | 36-question | 2 |
| 91 | iaat/scat-ratio | 1 |
| 92 | objectivesto | 2 |
| 93 | scid-p | 3 |
| 94 | c25p | 1 |
| 95 | non-overlap | 3 |
| 96 | lkb-ntcp | 1 |
| 97 | anti-dp | 1 |
| 98 | readership | 11 |
| 99 | paracetamol-group | 1 |
| 100 | srp+er | 3 |
| 101 | off-answer | 1 |
| 102 | mmfr | 1 |
| 103 | logor | 2 |
| 104 | fim-locomotor | 2 |
| 105 | ampa-receptor | 1 |
| 106 | 2010s | 2 |
| 107 | 1970-1980s | 2 |
| 108 | zazas | 1 |
| 109 | ff-stabs | 1 |
| 110 | lsbs | 3 |
| 111 | metabolics | 1 |
| 112 | studies.antibiotics | 1 |
| 113 | fymcs | 1 |
| 114 | cnpcs | 1 |
| 115 | taucs | 2 |
| 116 | sickbeds | 1 |
| 117 | dihydrosteroids | 1 |
| 118 | nannofluids | 1 |
| 119 | beam-ends | 2 |
| 120 | cycloaddends | 1 |
| 121 | key-words | 5 |
| 122 | keywords | 619 |
| 123 | 3-driuds | 2 |
| 124 | tube/devices | 1 |
| 125 | pairwise-distances | 1 |
| 126 | α-thioglycosides | 1 |
| 127 | 3-aminoglycosides | 1 |
| 128 | non-enrolees | 1 |
| 129 | advocacies | 1 |
| 130 | saliencies | 1 |
| 131 | outcomes.studies | 1 |
| 132 | pseudosymmetries | 1 |
| 133 | impuries | 1 |
| 134 | anharmonicities | 2 |
| 135 | a-velocities | 1 |
| 136 | isocycles | 4 |
| 137 | cis-angles | 1 |
| 138 | tgl-profiles | 1 |
| 139 | 3,3-diaryloxindoles | 1 |
| 140 | 1-glucosyl-5-halogeno-1,2,3-triazoles | 1 |
| 141 | response-outcomes | 1 |
| 142 | hypotheses/outcomes | 1 |
| 143 | combined-syndromes | 1 |
| 144 | spiropentanes | 1 |
| 145 | 3-aryl-3-arylmethoxyazetidines | 1 |
| 146 | 2-aryl-3h-indol-3-ones | 1 |
| 147 | 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4h-indazol-4-ones | 1 |
| 148 | 3-phenyl-1,2,4-triazin-6-ones | 1 |
| 149 | questiones | 1 |
| 150 | 4-fluoroquinolones | 1 |
| 151 | diplotypes | 18 |
| 152 | pc-scores | 1 |
| 153 | home-futures | 1 |
| 154 | vases | 1 |
| 155 | indoor-premises | 1 |
| 156 | gmf-rises | 1 |
| 157 | microlenses | 3 |
| 158 | phytoflagellates | 5 |
| 159 | pyrolyzates | 1 |
| 160 | sporophytes | 2 |
| 161 | pre-values | 1 |
| 162 | ri-values | 1 |
| 163 | m-values | 2 |
| 164 | 1-dapap-derivatives | 1 |
| 165 | objectives | 3,255 |
| 166 | spring-gauzes | 1 |
| 167 | scfs | 6 |
| 168 | video-recordings | 5 |
| 169 | off-springs | 2 |
| 170 | rest.deaths | 3 |
| 171 | mandais | 1 |
| 172 | it-mais/mais | 1 |
| 173 | codis | 2 |
| 174 | telis | 3 |
| 175 | sri/ssris | 1 |
| 176 | intent-to-treat-analysis | 1 |
| 177 | cox-analysis | 1 |
| 178 | read-backs | 1 |
| 179 | field.trials | 1 |
| 180 | alkanals | 1 |
| 181 | 5-halouracils | 1 |
| 182 | core-shells | 1 |
| 183 | bisabolenols | 1 |
| 184 | ice-creams | 2 |
| 185 | 8-items | 3 |
| 186 | subscales/items | 1 |
| 187 | sulphatrimethoprims | 1 |
| 188 | beads.harms | 1 |
| 189 | ileums | 2 |
| 190 | rectums | 1 |
| 191 | aminomorphinans | 2 |
| 192 | duocarmycins | 1 |
| 193 | filamins | 1 |
| 194 | deazaflavins | 2 |
| 195 | neotendons | 1 |
| 196 | job.conclusions | 1 |
| 197 | outcome.conclusions | 1 |
| 198 | counter-medications | 1 |
| 199 | keywords/combinations | 1 |
| 200 | peer-interactions | 2 |
| 201 | applications/fractions | 1 |
| 202 | road-connections | 1 |
| 203 | incompletions | 1 |
| 204 | participants/interventions | 1 |
| 205 | papagos | 1 |
| 206 | pmos | 1 |
| 207 | lumos | 4 |
| 208 | stem-tips | 1 |
| 209 | crkps | 1 |
| 210 | pcuacrs | 1 |
| 211 | radio-listeners | 1 |
| 212 | lsmrs | 1 |
| 213 | pcrrs | 1 |
| 214 | certificateless | 2 |
| 215 | non-effectiveness | 2 |
| 216 | successfulness | 3 |
| 217 | mini-compacts | 1 |
| 218 | clinician-subjects | 1 |
| 219 | study.subjects | 1 |
| 220 | monofluoromethylated-adducts | 1 |
| 221 | ihhts | 1 |
| 222 | jesuits | 1 |
| 223 | same.results | 1 |
| 224 | outcomes.results | 1 |
| 225 | cumulants | 5 |
| 226 | co-participants | 1 |
| 227 | arm-patients | 2 |
| 228 | pilot.patients | 1 |
| 229 | sf-measurements | 1 |
| 230 | pre-to-post-improvements | 1 |
| 231 | photo-currents | 1 |
| 232 | inafnts | 1 |
| 233 | phycobionts | 4 |
| 234 | idsa-us | 1 |
| 235 | vociferous | 1 |
| 236 | ryukyus | 1 |
| 237 | molvvs | 1 |
| 238 | sugar-coat | 1 |
| 239 | first-generation-320-detector-row-ct | 1 |
| 240 | ethanol-extract | 3 |
| 241 | bilirubin-ugt | 1 |
| 242 | dsmt | 2 |
| 243 | carevent | 1 |
| 244 | agnw-pedot | 1 |
| 245 | toes/forefoot | 1 |
| 246 | inco-test | 1 |
| 247 | sos-chromotest | 1 |
| 248 | com-on-checklist | 1 |
| 249 | 'vragenlijst | 1 |
| 250 | subtext | 1 |
| 251 | weissenau | 1 |
| 252 | gnu | 2 |
| 253 | estimate.low | 1 |
| 254 | pufa-index | 2 |
| 255 | oro-pharynx | 4 |
| 256 | heat-box | 1 |
| 257 | microimmunoassay | 1 |
| 258 | 'bureaucracy | 1 |
| 259 | tme-study | 1 |
| 260 | aire-study | 1 |
| 261 | consultation.they | 1 |
| 262 | ratkowsky | 1 |
| 263 | angiographicaly | 1 |
| 264 | 36.secondary | 1 |
| 265 | secretary | 33 |
| 266 | mortuary | 1 |
| 267 | co2-laser-surgery | 1 |
| 268 | backcountry | 4 |
| 269 | auto-responsibility | 1 |
| 270 | registy | 1 |
| 271 | 8,14-dihydroxyefaviremz | 1 |
| 272 | b3lyp/aug-cc-pvtz | 1 |
| 273 | outcomes.• | 2 |
| 274 | criteria® | 1 |